Clinical Trial Detail

NCT ID NCT02492867
Title A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase 0
Variant Requirements No
Sponsors University of Michigan Rogel Cancer Center
Indications

lung non-small cell carcinoma

Therapies

Durvalumab

Carboplatin + Paclitaxel

Age Groups: adult senior

No variant requirements are available.